Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice.
about
Peroxisome Proliferator-Activated Receptor-γ-Mediated Polarization of Macrophages in Leishmania InfectionEscaping Deleterious Immune Response in Their Hosts: Lessons from TrypanosomatidsThe site of the bite: Leishmania interaction with macrophages, neutrophils and the extracellular matrix in the dermisDifferences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discoveryIdentification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model systemEffect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survivalDolabelladienetriol, a compound from Dictyota pfaffii algae, inhibits the infection by Leishmania amazonensisProteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sicknessA novel role for Stat1 in phagosome acidification and natural host resistance to intracellular infection by Leishmania majorCD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infectionSynthetic glycovaccine protects against the bite of leishmania-infected sand flies.IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform.Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-leishmania response.Current status of interleukin-10 and regulatory T-cells in cancerDual effect of Lutzomyia longipalpis saliva on Leishmania braziliensis infection is mediated by distinct saliva-induced cellular recruitment into BALB/c mice earmiR-182 and miR-10a are key regulators of Treg specialisation and stability during Schistosome and Leishmania-associated inflammationRegulation of Leishmania (L.) amazonensis protein expression by host T cell dependent responses: differential expression of oligopeptidase B, tryparedoxin peroxidase and HSP70 isoforms in amastigotes isolated from BALB/c and BALB/c nude mice.Phlebotomine salivas inhibit immune inflammation-induced neutrophil migration via an autocrine DC-derived PGE2/IL-10 sequential pathwayNucleosides present on phlebotomine saliva induce immunossuppression and promote the infection establishment.Nucleosides from Phlebotomus papatasi salivary gland ameliorate murine collagen-induced arthritis by impairing dendritic cell functions.Identification of Synthetic and Natural Host Defense Peptides with Leishmanicidal Activity.T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?Differential Immune Response against Recombinant Leishmania donovani Peroxidoxin 1 and Peroxidoxin 2 Proteins in BALB/c Mice.CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis.Indotecan (LMP400) and AM13-55: two novel indenoisoquinolines show potential for treating visceral leishmaniasis.Exosome Secretion by the Parasitic Protozoan Leishmania within the Sand Fly Midgut.Leptin, CD4(+) T(reg) and the prospects for vaccination against H. pylori infection.Regulating immunity to malaria.The immunomodulatory factors of arthropod saliva and the potential for these factors to serve as vaccine targets to prevent pathogen transmission.Immune privilege in sites of chronic infection: Leishmania and regulatory T cells.Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathologyImmunization with a Toll-like receptor 7 and/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB/c miceIdentification of novel Leishmania major antigens that elicit IgG2a response in resistant and susceptible mice.Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence.Real-time in vivo green fluorescent protein imaging of a murine leishmaniasis model as a new tool for Leishmania vaccine and drug discovery.IL-17 promotes progression of cutaneous leishmaniasis in susceptible miceIL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection.Sex hormones and modulation of immunity against leishmaniasis.Inhibition of caspase-8 activity promotes protective Th1- and Th2-mediated immunity to Leishmania major infection.
P2860
Q21284970-D039FFEB-224B-4F8E-8CCA-67B3AB8AEA88Q26745974-5AF25775-60F0-487B-9880-20F97232E0F2Q26752781-88F5AC3D-D06C-4609-8FBA-BDAF9E724925Q28077110-6DBED3D4-B612-4B4B-94B1-58725A4F6555Q28477163-C76E0D14-1ED0-4A4E-918E-49DD24AA8F61Q28478343-73C39FDA-016A-4254-A2E9-57CA1BA845AAQ28483511-582F2926-F889-44F5-B435-F840FBE51070Q28817181-E273E68B-A8C6-4A34-98D9-3108D5AA5E67Q33432700-033D7279-936C-43D8-8AC9-651CEE2FDF05Q33614706-89DDA4FB-6113-4750-83A3-46A5668DFE82Q33732035-AEF5DC19-163A-46E6-9939-AE3E8DFBA920Q33979932-98C931A3-A9FB-44B7-AAFD-1AEA85723E05Q34033949-F27244B5-ED76-4E44-81D8-46AF99B02967Q34167908-2D72BB9A-F95D-44DC-9A9D-7F6181BFD69AQ34374026-624E27E4-99BE-4173-940B-D2A28796F428Q34711299-8B133E34-9842-4A6A-BF6F-35CCF63652DFQ34795455-E8A0FA1B-E54B-49B0-BB6E-AA9B2B34FA09Q35097514-95B4ABB0-AD17-4C0C-B918-71B61511C515Q35227682-555CE315-2E2B-4D60-90E9-FCCF88EE6522Q35300310-1CA33169-5678-4EFA-9C90-4D3A688DFEBAQ35368022-FAA588F9-FA74-44FE-990A-8AEC79FE808DQ35925429-348722A6-8EBB-47BE-A4C7-B96BD7968F14Q35928348-61EA26CA-CCBA-4EF4-9166-582C2BB8F286Q36035026-8CB0648F-BD5C-4BF5-A70C-29ECB37CA057Q36229713-CA8B0DF4-78F4-43F9-86AF-EDBEC1CB9A24Q36276947-4C681E33-D542-4020-9D91-5519CBB64007Q36279008-7A859CFE-DE1C-4984-BCBE-139B318781DAQ36316310-4C0B0D51-909C-46C8-9549-C67522A7727DQ36378338-AB59A458-57D9-4148-B6A7-8555F7FA6CE3Q36423181-45060BE8-E7A3-431B-AC1D-B41DF3926F46Q36593757-5BDE70EB-ED79-4E96-912A-7D6760763682Q36617322-99EF5C44-2559-4D53-B606-FB2D72517138Q36804294-AEF7BB99-D37D-4C8B-BBD1-47A8298260E1Q36868260-7452E3EE-2997-4142-9A7D-215F5D98A6E6Q36913750-FD88676E-69A5-40E0-869C-63033BA1D2D1Q36994297-75B94D9A-4B06-4B20-AA35-AF0D4227CA5AQ37135557-53985AAF-D451-4782-8C2A-100746322BACQ37359046-339F895A-4441-4BE7-9152-24A1BA84C302Q37383504-5A8BC7F6-2BF7-4899-859C-60A20748B4A7Q37496769-FFFDDC69-DACC-4639-9AD2-F91511F56097
P2860
Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Re-examination of the immunosu ...... Leishmania infection in mice.
@ast
Re-examination of the immunosu ...... Leishmania infection in mice.
@en
type
label
Re-examination of the immunosu ...... Leishmania infection in mice.
@ast
Re-examination of the immunosu ...... Leishmania infection in mice.
@en
prefLabel
Re-examination of the immunosu ...... Leishmania infection in mice.
@ast
Re-examination of the immunosu ...... Leishmania infection in mice.
@en
P2860
P1476
Re-examination of the immunosu ...... Leishmania infection in mice.
@en
P2093
Charles Anderson
David Sacks
P2860
P304
P356
10.1111/J.0105-2896.2004.00185.X
P577
2004-10-01T00:00:00Z